Dr. Michael Zinger, MD Obstetrics & Gynecology - Reproductive Endocrinology Medicare: Not Enrolled in Medicare Practice Location: 8 Corporate Center Dr, Suite 101, Melville, NY 11747 Phone: 631-752-0606 Fax: 631-752-0623 |
Dr. Joseph Edward Pena, M.D Obstetrics & Gynecology - Reproductive Endocrinology Medicare: Not Enrolled in Medicare Practice Location: 8 Corporate Center Dr, Suite 101, Melville, NY 11747 Phone: 631-752-0606 Fax: 631-752-0623 |
Satu M Kuokkanen, MD, PHD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 8 Corporate Center Dr, Suite 101, Melville, NY 11747 Phone: 631-752-0606 Fax: 631-752-0623 |
Dr. Robert Raphael Weiss, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 540 Bardini Drive, Melville, NY 11747 Phone: 631-425-1871 Fax: 631-425-1360 |
Dr. Steven Hal Brenner, M.D. Obstetrics & Gynecology - Reproductive Endocrinology Medicare: Not Enrolled in Medicare Practice Location: 8 Corporate Center Dr, Suite 101, Melville, NY 11747 Phone: 631-752-0606 Fax: 631-752-0623 |
News Archive
Research in a Japanese cohort of patients with non-small-cell lung cancer indicates that the frequency of BRAF mutations is low and their presence has limited prognostic significance.
The Huntington Study Group (HSG), under the leadership of Samuel Frank, MD, Principal Investigator, (Boston University School of Medicine) and Claudia Testa, MD, PhD, co-Principal Investigator (Virginia Commonwealth University), is conducting a clinical trial with a formulation of the novel drug SD-809 in the treatment of HD the United States and Canada.
The multicentre trial coordinated by the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku, Finland, shows that lower socioeconomic status in childhood is associated with arterial stiffness in adulthood.
A new study has found that certain factors are linked with a person's decision to leave the hospital against the advice of his or her care provider.
Safeway Inc. today launched its annual October chain-wide breast cancer fundraising initiative. The company has raised more than $94 million for the cause since 2001.
› Verified 8 days ago